| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |